Germany· DE-A57-38fdbe6a8afcb762
Carbadura Retard
A carbamazepine product containing carbamazepine, registered in Germany by Viatris Germany Gmbh. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Carbamazepine is registered in 18 of 19 countries.
Countries holding a registration under ATC N03AF01 (carbamazepine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 10 of them publish a price we can compare per daily dose
Carbamazepine · ATC N03AF01
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carbamazepine costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $0.39 in France to $1.99 in United States — a ×5.2 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Carbamazepine · price per daily dose (1 g)
USD · FX 28 Sept 2026
- US United States$1.99 (acquisition cost)
- CH Switzerland$1.35
- IT Italy$0.46
- FR France$0.39
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Carbamazepine
- Manufacturer
- Viatris Germany Gmbh
- Country
- Germany (DE)
- ATC code
- N03AF01
- ATC class
- Carbamazepine
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
614 interactions on record for carbamazepine.
Graded by severity as the source publishes them — 136 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Carbamazepine · interactions on record
614 records
- 136 severe
- 250 moderate
- 6 minor
- 133 info
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- NaldemedineA06AH05severe
- EliglustatA16AX10severe
89 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N03AF01
Carbamazepine, as other registers publish it.
- PolandAmizepinZakłady Farmaceutyczne POLPHARMA S.A.
- United KingdomArbil MR 200mg tabletsSun Pharma UK Ltd
- United KingdomArbil MR 400mg tabletsSun Pharma UK Ltd
- CzechiaBISTONZentiva, k.s., Praha
- GermanyCarba RetardDesitin Arzneimittel Gmbh
- GermanyCarbaduraViatris Germany Gmbh
- GermanyCarbaduraMylan Germany Gmbh
- GermanyCarbadura RetardMylan Germany Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6198e4bd-d589-4865-b8ae-274359dd7185 GET /v1/drugs/6198e4bd-d589-4865-b8ae-274359dd7185?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Carbamazepine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about carbamazepine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.